Drug Shortage Report for MYLAN-ATORVASTATIN

Last updated on 2017-07-25 History
Report ID 10714
Drug Identification Number 02392976
Brand name MYLAN-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90BT
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-08-17
Actual start date
Estimated end date
Actual end date 2017-07-24
Shortage status Avoided shortage
Updated date 2017-07-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-07-25 French Compare
v9 2017-07-25 English Compare
v8 2017-07-18 French Compare
v7 2017-07-18 English Compare
v6 2017-06-22 French Compare
v5 2017-06-22 English Compare
v4 2017-06-22 English Compare
v3 2017-05-19 French Compare
v2 2017-05-19 English Compare
v1 2017-05-19 English Compare

Showing 1 to 10 of 10